AG
RXRX icon

Algert Global’s Recursion Pharmaceuticals RXRX Stock Holding History

Algert Global’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Sell
596,877
-67,666
-10% -$261K 0.03% 735
2025
Q4 		$2.72M Buy
+664,543
New +$3.29M 0.04% 623
2024
Q3 		– Sell
-17,158
Closed -$129K – 1533
2024
Q2 		$129K Buy
+17,158
New +$150K ﹤0.01% 1360

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Algert Global's RXRX Position: Q1 2026 in Review

Algert Global reduced its Recursion Pharmaceuticals (RXRX) stake by 10% in Q1 2026, selling an estimated $261K and leaving 596,877 shares worth $1.83M. The position accounts for 0.03% of the portfolio, ranked #735.

Algert Global first reported a position in RXRX in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.72M in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Algert Global held 596,877 shares of Recursion Pharmaceuticals worth $1.83M as of Q1 2026.
  • Algert Global sold 67,666 Recursion Pharmaceuticals shares in Q1 2026, an estimated $261K.
  • Recursion Pharmaceuticals made up 0.03% of Algert Global's portfolio in Q1 2026, its #735 holding.
  • Algert Global first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • Algert Global's Recursion Pharmaceuticals position peaked at $2.72M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.